Molecular basis of DEL phenotype in the Chinese population by Juan Gu et al.
Gu et al. BMC Medical Genetics 2014, 15:54
http://www.biomedcentral.com/1471-2350/15/54RESEARCH ARTICLE Open AccessMolecular basis of DEL phenotype in the Chinese
population
Juan Gu1,2, Xue-Dong Wang1,2*, Chao-Peng Shao1,2,3, Jun Wang1,2, An-Yuan Sun1,2,4, Li-Hua Huang1,2
and Zhao-Lin Pan1,2Abstract
Background: Rh blood group system is the most complex and immunogenetic blood group system. Prevalent
RHD alleles vary in different populations. We conducted the present study to examine the genotype of DEL
individuals and to elucidate whether novel alleles exist in the Chinese population.
Methods: DEL phenotype was identified by a serologic adsorption-elution method. The nucleotide sequences of
ten RHD exons and exon-intron boundary regions were evaluated by RHD gene-specific PCR-SSP and sequencing.
Results: Of 42306 samples from individual donors and patients, 165 samples were typed as D-negative. Among
these D-negative samples, 41 DEL individuals were observed. Thirty-seven DELs were confirmed to have the
RHD1227A allele. Two DELs seemed to have RHD-CE-D hybrid alleles, including one RHD-CE (4–7)-D and one
RHD-CE (2–5)-D. Two novel RHD alleles were found among the rest of the DEL samples, including one RHD93T > A
and one RHD838G > A.
Conclusion: In this study, about 24.85% (41/165) of the apparent D-negative Chinese individuals were DEL.
RHD1227G > A is the most frequent allele in Chinese DEL phenotypes, accounting for 90.24% (37/41). The RHD-CE-D
hybrid allele might be the second most frequent DEL allele in the Chinese population. Our study would contribute
to the understanding of the molecular mechanism underlying D antigen expression of DEL individuals and provide
useful information for designing suitable genotyping strategies in RhD-negative individuals in Asia.
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The Rh blood group system is the most complex and
immunogenetic blood group system. The Rh antigens
are encoded by a pair of homologous genes, RHD and
RHCE, which are located on chromosome 1p34.3-36.1.
The two genes have opposite orientations at the RH
locus, each gene has 10 exons and their sequences are
highly homologous. RHD encodes the D polypeptide,
while RHCE gives rise to the C/c and E/e polymorphisms.
The RHD gene is flanked by an upstream Rh box (at its 5′
end) and a downstream Rh box (at its 3′ end). Both Rh
boxes have a length of ≈ 9000 bp in identical orientation* Correspondence: wxd729@126.com
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unless otherwise stated.and share 98.6% homology. The region (breakpoint
region) in which the RHD deletion occurs is located
within a stretch of 1463 bp in which both Rh boxes have
an identical sequence (identity region). The hybrid Rh
box, only present when the RHD gene is deleted via the
proposed mechanism of unequal crossing over, contains a
sequence identical to that of the upstream Rh box in the
5′ part preceding the identity region, and the 3′ part follo-
wing the identity region is identical to the downstream Rh
box sequence in European people [1]. Studies of the blood
group system have shown that racial differences exist not
only in the genetic background of the RHD gene but also
in the frequencies of the RHD allele [2-5]. About 15% of
European people are D-negative phenotype and are mostly
associated with the deletion of RHD between the up-
stream and the downstream Rhesus boxes. Interestingly,
several studies, however, have revealed that there has
been the presence of the RHD gene in the majority ofThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Africans have an inactive RHD gene of pseudogene
(RHDψ) with a 37 base pair (bp) insertion and a nonsense
mutation [6]. In the Asian population, RHDψ is rare, and
a certain percentage of RhD-negative individuals have
RHD-CE-DS hybrid gene or RHD1227A allele. In contrast
to the European population, the RhD-negative blood type
only occurs in 0.3-0.5% of the Chinese population; [7]
however, nearly 30% of the RhD-negative individuals
belong to the DEL phenotype, which is a rare variant of
the Rh system with a grossly intact RHD gene, of which
one is the 1227G > A mutation that probably disrupts
normal intron splicing. In the European population, the
frequency of DEL phenotype was 1:3030 and that of
RHD1227A allele was 1:9091 [8].
DEL phenotypes derive from several mechanisms. Pre-
vious studies showed that DEL phenotype was associated
with either a long deletion of RHD gene from intron 8
to intron 9, including whole exon 9, or a missense muta-
tion (RHD1227G > A) in exon 9, or splice-site mutation,
including RHD (IVS3 + 1G >A), or a frameshift mutation,
including RHD (X418 L) or a mutation in the coding
region, or premature stop codons [8-13]. Those studies
indicate the D-negative trait may be generated by multiple
molecular mechanisms.
DEL is the most frequent D variant phenotype in the
RhD-negative Chinese population that is confirmed by the
adsorption-elute test. Moreover, previous studies through
genomic DNA analysis showed that the RHD1227 allele is
the prevalent causal mutation for DEL individuals in
China. Those individuals possess one or two of these
alleles with Ccee or CCee phenotypes. Whether there are
other DEL alleles in the Chinese population is not yet
resolved. The aim of this study was therefore to collect
large numbers of blood samples to explore the molecular
basis of DEL in the Chinese population.
Methods
Blood samples
EDTA-anticoagulated peripheral blood samples were
collected from outpatients, inpatient and blood donors
at the Anhui Provincial Hospital, the Affiliated Hospital
of Anhui Medical University, the Clinical College of
Nanjing Medical University, the Affiliated Hospital of
Gulin Medical College, the Shaoxing People’s Hospital of
Zhejiang Province, the 4th Affiliated Hospital of Jiangsu
University, Blood Center of Anhui Province, Shenzhen
Blood Center of Guangdong Province and Wuxi Blood
Center of Jiangsu Province in the southeast China. This
study was approved by the institutional Ethics Review
Board of Nanjing Medical University and all subjects
provided written informed consent to their participa-
tion in it.Serological studies
Rh blood type phenotype D status was determined by a
microplate technique with IgM monoclonal anti-D re-
agent (Immucor, Norcross, GA; Gamma Biologicals,
Houston, TX) [14]. Subsequently, the Rh C/c and E/e anti-
gens were determined by using agglutinating monoclonal
anti-C (Novaclone, Dominion Biologicals, Dartmouth,
Canada), anti-E (Gamma Biologicals), anti-c (Immucor)
and anti-e reagents (Immucor). All samples that were
negative with anti-D in the direct agglutination were
retested by using the indirect anti-human globulin test
(IAT). The indirect anti-human globulin test was used to
detect weak D or partial D phenotype. Furthermore, sam-
ples typed as D-negative by the IAT were retested for the
DEL phenotype through an adsorption-elution test in
tubes. If the result was positive (≥1+), the sample was
determined to belong to the DEL phenotype. If the result




Genomic DNA of DEL samples was prepared using
QIAamp DNA Blood Mini Kit according to the manu-
facturer's recommendations (Qiagen, Valencia, CA, USA).
The column-bound circulatory DNA was eluted in dis-
tilled water and quantified by using a spectrophotometer
(NanoDrop 2000c, Thermo Scientific, Wilmington, DE,
USA).
Amplification of RHD exons
Primers for RHD exons 1 to 10 were given in Table 1. β-
actin gene was used as an internal control. Amplification
was carried out in a thermal cycler (Veriti 96, Applied
Biosystems, Foster City, CA). Cycling conditions for
RHD exon 1 and 10 were denatured at 95°C for 5 min,
then 40 cycles of 30s at 94°C, annealing time was 40 sec-
onds at 64°C (exon 2–4, 6, 8), 62°C (exon 1, 7, 9, 10,
RHD1227A) and 60°C (exon 5), and extension for 1 min
at 72°C. The final extension was at 72°C for 10 minutes.
PCR products were visualized by electrophoresis on a
1.5% agarose gel with ethidium bromide staining and
these were photographed under UV light.
PCR-restriction fragment length polymorphism
(PCR-RFLP) for RHD zygosity determination
The PCR amplification was performed by using the
expand high-fidelity PCR system with primers rez7
(consensus, 5′ of the Rh box identity region) and rnb31
(specific for downstream of the Rh box, 3′ of the Rh box
identity region) [1]. PCR products were digested with
PstI at 37°C for 3 h, and the fragments were resolved
by electrophoresis on a 1.5% agarose gel with ethidium
Table 1 Primers used for PCR analysis and DNA sequencing
Primer name* Sequence 5′ to 3′ Location# Specificity Product size (bp)
E1-s ATGCCTGGTGCTGGTGGA promoter, -43 to -26 RHD/CE
228
E1-a ATTTGCTCCTGTGACCACTT intron 1, 37 to 18 RHD
E1-seq ATGCCTGGTGCTGGTGGA
E2-s TGACGAGTGAAACTCTATCTCGAT intron 1, -1064 to -1041 RHD
1475
E2-a GGATTCCTTGTGATACACGGAGTAG intron 2, 224 to 200 RHD
E2-seq TGACGAGTGAAACTCTATCTCGAT
E3-s GTCGTCCTGGCTCTCCCTCTCT intron 2, -29 to -8 RHD
219
E3-a CTTTTCTCCCAGGTCCCTCCT intron 3, 39 to 19 RHD/CE
E3-seq GTCGTCCTGGCTCTCCCTCTCT
E4-s GCCGACACTCACTGCTCTTAC intron 3, -36 to -16 RHD/CE
378
E4-a TGAACCTGCTCTGTGAAGTGC intron 4, 194 to 174 RHD
E4-seq GCCGACACTCACTGCTCTTAC
E5-s TACCTTTGAATTAAGCACTTCACAG intron 4, -267 to -233 RHD
1458
E5-a TTATTGGCTACTTGGTGCC intron 5, 1024 to 1006 RHD
E5-seq TACCTTTGAATTAAGCACTTCACAG
E6-s CAGGGTTGCCTTGTTCCCA intron 5, -95 to -77 RHD/CE
274
E6-a CTTCAGCCAAAGCAGAGGAGG intron 6, 41 to 21 RHD
E6-seq CAGGGTTGCCTTGTTCCCA
E7-s TGCCCATCCCCCTTTGGTGGCC intron 6, -106 to -85 RHD
411
E7-a CCAAGGTAGGGGCTGGACAG intron 7, 171 to 152 RHD
E7-seq TGCCCATCCCCCTTTGGTGGCC
E8-s GGTCAGGAGTTCGAGATCAC intron 7, -594 to -575 RHD
709
E8-a TGGCAATGGTGGAAGAAAG intron 8, 35 to 16 RHD/CE
E8-seq GGTCAGGAGTTCGAGATCAC
E9-s CTGTCGTTTTGACACACAATATTTC intron 8, -91 to -67 RHD
190
E9-a CACGTTAATAGGTGAAAAATCTTACC intron 9, 25 to exon 9, 1227 RHD
E9-seq CTGTCGTTTTGACACACAATATTTC
E10-s CAAGAGATCAAGCCAAAATCAGT intron 9, -67 to -45 RHD/CE
382
E10-a AGCTTACTGGATGACCACCA 3’UTR, 291 to 272 RHD
E10-seq CAAGAGATCAAGCCAAAATCAGT
RHD1227A-s GATGACCAAGTTTTCTGGAAA exon 9, 1207 to 1227 RHD1227A
109





*s = sense primer; a = antisense primer. seq = sequencing primer.
#The positions of the synthetic oligonucleotides are indicated relative to their distances from the first nucleotide position of the start codon ATG for all primers in
the promoter and in the exons or relative to their adjacent exon-intron boundaries for all other primers.
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Purification and sequencing
Amplified DNA products were purified using an isola-
tion kit (NucleoSpin Extract II, Macherey-Nagel, Düren,
Germany) and sequenced on a genetic analyzer by DNA
technology (ABI 3130 XL, Applied Biosystems, Aarhus,Denmark). The complete RHD exons 1 to 10 including
adjacent intron regions were sequenced from PCR prod-
ucts with cycle-sequencing kits (BigDye-terminators
v.1.1; Applied Biosystems, Weiterstadt, Germany) and
Sequence determination of amplicons was performed on
both strands using the respective PCR primers with an
ABI PRISM 3730 automated sequencer (Applied Biosys-
tems, Foster City, USA). The nucleotide and deduced
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with the published sequences using computer software
(Lasergene 99, DNASTAR, Madison, WI) as a sequencing
analysis tool. All sequenced PCR products were compared
with GenBank Accession Number BN000065.
Results
Serologic studies
A total of 165 apparent D-negative samples were found
among the 42306 blood donors and patients through the
microplate determination. When the D-negative samples
were retested by the IAT and the adsorption-elution test,
a total of 41 DELs were found among these samples. In
the Chinese population examined, approximately 24.58%
(41/165) of the apparent D-negative individuals belong
to DEL phenotypes (Table 2).
Molecular characterization of DELs
Among the 41 DELs samples, a total of 37 samples were
determined to have the RHD1227A allele by PCR-SSP
analysis and sequencing (Table 2, Figures 1a and 2a),
accounting for 90.24% (37/41) in the Chinese DEL indi-
viduals. All of these individuals carrying RHD1227A
allele were demonstrated that the mutation is located in
the splice site at the exon 9 and intron 9 junctions. The
remaining four DEL samples did not have RHD1227A
(Figure 1a; lines 6 to 9). Two samples seemed to have
RHD-CE-D hybrid alleles. According to the PCR-SSP for
the RHD gene exons 1 to 10 determination, the first
sample (sample No: 13039) lacked RHD exons 4 to7, the
second sample (sample No: 13038) lacked exons 2 to 5
(Figure 1b and c). The two samples were confirmed to
be RHD-CE (4–7)-D and RHD-CE (2–5)-D, respectively.
No mutation was found in the RHD-specific exons by
sequencing.
Two novel RHD alleles were found in the remaining
two DEL samples. One sample (sample No: 13040) was
found to have a RHD93T > A mutation (Figure 2b), theTable 2 Results of phenotype and genotype analyses of the 4
Sample no. Numberof subjects
RhD
Micro-plate IAT Ads
13001-13030 30 – –
13031-13033 3 – –
13034-13035 2 – –
13036 1 – –
13037 1 – –
13038 1 – –
13039 1 – –
13040 1 – –
13041 1 – –
*Presence (+) or absence (–) of the RHD gene.other sample (sample No: 13041) had a RHD838G > A
mutation (Figure 2c). Their DNA sequences were depos-
ited under GenBank accession numbers: RHD93T > A
(KJ558352 for exon 1), RHD838G > A (KJ558353 for
exon 6). The RHD93T > A and RHD838G > A alleles
were missense mutations, which caused F31L and A280T
amino acid mutations, respectively, both of the two muta-
tions occurred in the RhD transmembrane domain. The
samples with RHD93T > A and RHD838G >A alleles
belong to Ccee phenotype. The sample assigned to
RHD93T >A allele was found to be RHD+/RHD + homo-
zygote by PCR-RFLP analysis and the other sample
with RHD838G > A allele was RHD+/RHD– heterozygote
(Table 2).
Discussion
DEL phenotype was determined on the basis of non-
agglutination by the IAT procedure and positive result
by an adsorption-elution technique. Molecular studies
have shown that a heterogeneous array of variant RHD
allele can result in the DEL phenotype [15]. Körmöczi
and colleagues suggested that the DEL phenotypes might
be subdivided into two groups, partial DEL with cha-
racteristic D epitope loss caused by either RHD-CE-D
hybrid genes or RHD point mutation such as carrier of
RHD (IVS3 + 1G > A) affecting extracellular RhD loops
and complete DEL where the majority of D epitopes are
conserved such as RHD1227A [16]. According to the
published data [9,17] and our results, the RHD1227A
allele was the most frequent allele in the Chinese DEL
individuals. In our study, two DELs seemed to have RHD-
CE-D hybrid alleles, including one RHD-CE (4–7)-D and
one RHD-CE (2–5)-D. The RHD-CE (4–7)-D was thought
to be a DEL allele by our laboratory, while a similar
hybrid RHD-CE (4–7)-D was described as D-negative
[10]. Whether there were miniscule differences between
these two alleles has not yet been clarified. The RHD-CE
(2–5)-D was similar to the RH allele that is also called DVI1 DEL samples
RhCcEe RHDzygosity* RHD alleleorption/elute
+ Ccee RHD+/RHD- RHD1227A
+ CCee RHD+/RHD- RHD1227A
+ Ccee RHD+/RHD+ RHD1227A
+ CCEe RHD+/RHD- RHD1227A
+ CcEe RHD+/RHD- RHD1227A
+ Ccee RHD+/RHD- RHD-CE (2-5)-D
+ Ccee RHD+/RHD- RHD-CE (4-7)-D
+ Ccee RHD+/RHD+ RHD93T>A
+ Ccee RHD+/RHD- RHD838G>A
Figure 1 Results of the PCR-SSP analysis. In all lanes, a 473-bp product was amplified as the internal positive control; M, molecular marker
(2000, 1000, 750, 500, 250 and 100 bp, respectively). (a) PCR-SSP for RHD1227A allele in 9 DEL samples. Lanes 1 to 9 showed the PCR-SSP results
of 9 DEL samples. Lanes 1 to 5 showed that the RHD1227A specific amplifications (band of 109 bp) were positive (Sample No.13001-13005). They
were shown as representatives of 37 DEL individuals carrying RHD1227A allele. Lane 6 to 9 showed that the RHD1227A specific amplifications
were negative (Sample No.13038-13041). (b) PCR-SSP for RHD-CE (4–7)-D in one DEL sample (Sample No.13039). Lanes 1 to 10 showed the
PCR-SSP results of the RHD exons 1 to 10; Lanes 4 to 7 showed that the RHD specific amplifications were negative for exons 4 to 7; RHD specific
amplifications were positive for exons 1 to 3 and 8 to 10. (c) PCR-SSP for RHD-CE (2–5)-D in one DEL sample (Sample No.13038); lanes 1 to 10
showed the PCR-SSP results of the RHD exons 1 to 10; Lanes 2 to 5 showed that the RHD specific amplifications were negative for exons 2 to 5;
RHD specific amplifications were positive for exons 1, 6 to 10.
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were caused by a trans effect of C on a haplotype contain-
ing a weak D allele [18]. Whether the DVI-like DEL has a
similar mechanism, that the DEL was resulted from the
influence of C in trans on a haplotype with a partial DFigure 2 Electropherograms of RHD DNA sequencing. (a) Sequencing
nucleotide mutation between RHD exon 9 and intron 9. A representative e
analysis of the RHD93T > A allele in one DEL sample (Sample No.13040). Th
(c) Sequencing analysis of the RHD838G > A allele in one DEL sample (Sam
in RHD exon 6.allele, needs to be further analysed. The hybrid gene indi-
viduals were detected with Rh box zygosity. They were
found to be RHD+/RHD– heterozygote (Table 2). These
results may also be in concordance with the studies of
Li et al [17].analysis of the RHD1227A allele. The arrow indicates the position of
xample of 37 RHD1227A genotyped cases is shown; (b) Sequencing
e arrow indicates the position of nucleotide mutation in RHD exon 1;
ple No.13041). The arrow indicates the position of nucleotide mutation
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RHD838G > A alleles showed slightly stronger positive re-
sults (2+) than other DEL samples (1+) in the adsorption-
elution test. This phenomenon suggested that there might
be scant differences in the D antigen between these two
samples and other DELs. The possibility that these two
samples might be two new kinds of weak DS could not be
excluded.
DEL is the weakest D positive phenotype, whether the
potential danger that DEL RBCs might cause a clinical
transfusion reaction cannot be completely excluded. Re-
cipients with a truly D-negative phenotype developed
anti-D after transfusion with DEL RBCs [19,20]. Re-
cently, Richard and his colleagues found a patient with a
DEL phenotype who developed anti-D [11,12]. Other
members of our team have not yet reported analogous
cases in the Chinese population. Shao and his colleagues
found that the Asian type DEL displays the complete
repertoire of RhD antigen epitopes. They suggested
that people in East Asia who carry the DEL variants
could safely receive blood transfusion from RhD-
positive donors [21]. Our previous study also supported
the biochemical observations that DEL variants express
normal RhD and pose virtually no risk of inducing anti-D
antibodies [22]. We also confirmed that this is an
exact model test that people carrying the DEL variants
can safely receive blood transfusion from RhD-positive
donors.
Throughout the world, the majority of DEL pheno-
types are misinterpreted as D-negative owing to the
limits of routine typing. For this reason, the recipient
with a truly D-negative phenotype would be likely to
develop into anti-D alloimmunization after transfusion
with DEL RBCs. So it would be of interest to rou-
tinely screen serologically D-negative donors for the
presence of the RHD gene in order to discriminate all
clinically relevant RHD DEL alleles. An optimized
PCR strategy that checks for RHD-specific polymorphism,
supplemented by the specific detection of aberrant al-
leles, would be a good choice. Samples carrying RHD
deletion should be correctly typed by multiple PCR
utilized for RHD genotyping. Testing additional RHD
exons would improve the specificity of RhD predic-
tion. Although direct sequencing is currently the gold
standard in mutation identification, it is still relatively
laborious and expensive, whereas PCR-SSP as a one-
step method is less expensive and less time consum-
ing. In any case, the combined use of serologic and
molecular D typing techniques may reduce the num-
ber of such transfusion incidents. All of these findings
suggested that it might be important to explore the
molecular basis of DEL individuals in Asia and to form
molecular screening techniques to determine the DEL
phenotype accurately.Conclusion
In this study, about 24.85% (41/165) of the apparent
D-negative Chinese individuals were DEL. RHD1227G >A
is the most frequent allele in Chinese DEL phenotypes,
accounting for 90.24% (37/41). The RHD-CE-D hybrid
allele might be the second most frequent DEL allele in the
Chinese population. Novel DEL alleles are still relatively
rare and frequencies of occurrence are also very low. Our
study would contribute to the understanding of the
molecular mechanism underlying D antigen expression
of DEL individuals and provide useful information for
designing suitable genotyping and transfusion strategies
for the RhD-negative individuals in Asia.
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